Market Size of Global Aesthetic Fillers Industry
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 3.48 Billion |
| Market Size (2029) | USD 4.77 Billion |
| CAGR (2024 - 2029) | 6.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Global Aesthetic Fillers Market Analysis
The Global Aesthetic Fillers Market size is estimated at USD 3.48 billion in 2024, and is expected to reach USD 4.77 billion by 2029, growing at a CAGR of 6.5% during the forecast period (2024-2029).
The growth of the aesthetic fillers market can be attributed to various factors such as the increasing demand for facial aesthetics, growing acceptance of tissue fillers with the increase in dermal filler surgeries, and growing attention on facial aesthetics among the older age population.
The increasing demand for aesthetic procedures boosts the need for aesthetic fillers, which is anticipated to contribute to market growth. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) survey released in September 2023, around 14.9 million cosmetic surgical procedures and 18.8 million non-surgical cosmetic procedures were performed worldwide in 2022, which showed an overall 11.2% increase from the previous year. Thus, this increase in aesthetic procedures is expected to drive the market’s growth during the forecast period.
Furthermore, as per the above-mentioned source, the highest number of aesthetic procedures were performed in the United States (22%), followed by Brazil (8.9%) and Japan (7.3%). Thus, the higher demand for aesthetic procedures in developed countries is expected to augment the growth of the aesthetic fillers market during the forecast period.
The growing popularity of anti-aging therapies and the rising acceptability of tissue fillers, in conjunction with the increase in dermal filler procedures, stimulate the demand for aesthetic fillers in the market. For instance, in August 2022, Allergan Aesthetics, an AbbVie company, received the United States Food and Drug Administration (FDA) approval of Juvederm Volux XC for the improvement of jawline in adults over the age of 21 with moderate to severe loss of jawline definition.
In January 2022, the US Food and Drug Administration (FDA) approved Teoxane's RHA Redensity, a gel implant or dermal filler, which can be injected into specific areas of facial tissue to reduce the appearance of lines and wrinkles. Thus, such approvals are expected to fuel the availability of novel aesthetic fillers in the market, which, in turn, is anticipated to propel the market’s growth during the forecast period.
Therefore, the growing demand for facial aesthetics, the wide acceptance of tissue fillers with the rise in dermal filler surgeries, and the ever-increasing focus on facial aesthetics among the population fuel market growth. However, side effects associated with dermal fillers and the adverse impact of unregistered practitioners are expected to impede the development of the global market during the forecast period.
